Date | Time | Source | Headline | Symbol | Company |
06/01/2024 | 11:49AM | GlobeNewswire Inc. | La Journée des Films thaïlandais à Paris captive le public parisien avec une première prestigieuse | | |
06/01/2024 | 11:40AM | PR Newswire (US) | Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling! | | |
06/01/2024 | 11:23AM | PR Newswire (Canada) | Unifor members begin strike at Gibraltar copper mine | | |
06/01/2024 | 11:00AM | PR Newswire (US) | ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer | | |
06/01/2024 | 10:34AM | PR Newswire (US) | The Agency's Agents Named Among Top Producers in the Country by RealTrends + Tom Ferry The Thousand 2024 | | |
06/01/2024 | 10:04AM | PR Newswire (Canada) | Déclaration des ministres Gary Anandasangaree, Patty Hajdu, Dan Vandal et Pascale St-Onge à l'occasion du Mois national de l'histoire autochtone | | |
06/01/2024 | 10:00AM | GlobeNewswire Inc. | Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) | TG:GE9 | Genmab AS |
06/01/2024 | 10:00AM | Business Wire | Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) | NASDAQ:GMAB | Genmab AS |
06/01/2024 | 10:00AM | Business Wire | "Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024! | | |
06/01/2024 | 10:00AM | Business Wire | Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) | NASDAQ:BNTX | BioNTech SE |
06/01/2024 | 10:00AM | GlobeNewswire Inc. | Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) | NASDAQ:BNTX | BioNTech SE |
06/01/2024 | 10:00AM | GlobeNewswire Inc. | Phase-2-Daten für Prüfpräparat Acasunlimab (DuoBody® -PD-L1x4-1BB) in Kombination mit Pembrolizumab: Signifikante klinische Aktivität bei vorbehandeltem, metastasiertem nicht-kleinzelligem Lungenkarzinom | XE:22UA | BioNTech SE |
06/01/2024 | 10:00AM | GlobeNewswire Inc. | Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) | TG:22UA | BioNTech SE |
06/01/2024 | 10:00AM | GlobeNewswire Inc. | Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | NASDAQ:BDTX | Black Diamond Therapeutics Inc |
06/01/2024 | 10:00AM | GlobeNewswire Inc. | Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) | XE:22UA | BioNTech SE |
06/01/2024 | 10:00AM | GlobeNewswire Inc. | Phase-2-Daten für Prüfpräparat Acasunlimab (DuoBody® -PD-L1x4-1BB) in Kombination mit Pembrolizumab: Signifikante klinische Aktivität bei vorbehandeltem, metastasiertem nicht-kleinzelligem Lungenkarzinom | TG:22UA | BioNTech SE |
06/01/2024 | 10:00AM | Business Wire | First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024 | | |
06/01/2024 | 10:00AM | PR Newswire (US) | Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple | | |
06/01/2024 | 9:53AM | PR Newswire (Canada) | Statement from Ministers Gary Anandasangaree, Patty Hajdu, Dan Vandal, and Pascale St-Onge on National Indigenous History Month | | |
06/01/2024 | 9:30AM | Business Wire | Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC | | |
06/01/2024 | 9:30AM | PR Newswire (Canada) | Message from the Governor General on Pride Month | | |
06/01/2024 | 9:30AM | PR Newswire (US) | FractIt Revolutionizes Real Estate: Completes Pilot with Tokenization of Luxury Property on Blockchain | | |
06/01/2024 | 9:30AM | PR Newswire (Canada) | Message de la gouverneure générale à l'occasion du Mois de la fierté | | |
06/01/2024 | 9:15AM | Business Wire | オムディアのRANベンダー・レポートでマべニアがトップに輝く | | |
06/01/2024 | 9:14AM | GlobeNewswire Inc. | Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing | | |
06/01/2024 | 9:00AM | Business Wire | Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment | | |
06/01/2024 | 9:00AM | Business Wire | Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Statement by Minister Khera on Italian Heritage Month | | |
06/01/2024 | 9:00AM | PR Newswire (US) | Vincent Todd Announces the Introduction of Todd Agriscience | | |
06/01/2024 | 9:00AM | PR Newswire (US) | Beverly Hills MD Celebrates Its 10th Anniversary | | |